Rockefeller Capital Management
CKPT

Rockefeller Capital Management’s Checkpoint Therapeutics CKPT Stock Holding History

Rockefeller Capital Management’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-529
Closed -$2K – 2306
2022
Q4 		$2K Sell
529
-1
-0.2% -$7 ﹤0.01% 3545
2022
Q3 		$5K Hold
530
– – ﹤0.01% 3321
2022
Q2 		$5K Hold
530
– – ﹤0.01% 3427
2022
Q1 		$9K Hold
530
– – ﹤0.01% 3095
2021
Q4 		$16K Hold
530
– – ﹤0.01% 2742
2021
Q3 		$17K Hold
530
– – ﹤0.01% 2647
2021
Q2 		$15K Hold
530
– – ﹤0.01% 2601
2021
Q1 		$16K Buy
+530
New +$17.8K ﹤0.01% 2374

Other funds holding CKPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Rockefeller Capital Management's CKPT Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Checkpoint Therapeutics (CKPT) in Q1 2023, closing a stake of 529 shares — an estimated $2K sold.

Rockefeller Capital Management first reported a position in CKPT in Q1 2021 and held it in 8 quarters. The position peaked at $17K in Q3 2021. 34 funds tracked by Wall St. Rank hold CKPT as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Checkpoint Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 529 Checkpoint Therapeutics shares in Q1 2023, an estimated $2K.
  • Rockefeller Capital Management first reported a position in Checkpoint Therapeutics in Q1 2021 and held it in 8 quarters.
  • Rockefeller Capital Management's Checkpoint Therapeutics position peaked at $17K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.